Osiris Therapeutics (OSIR) Tops Q3 Revs, Loss Views

November 5, 2012 8:08 AM EST Send to a Friend
Get Alerts OSIR Hot Sheet
Price: $19.27 --0%

Financial Fact:
Income from operations: 1.84M

Today's EPS Names:
More
Trade OSIR Now!
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.15 million versus the consensus estimate of $1.89 million.

For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment